Search bioRxiv⌕ Search

bioRxiv · 10.1101/2020.11.27.401851

Data-driven beamforming techniques to attenuate ballistocardiogram (BCG) artefacts in EEG-fMRI without detecting cardiac pulses in electrocardiography (ECG) recordings

Abstract

Simultaneous recording of EEG and fMRI is a very promising non-invasive neuroimaging technique, providing a wide range of complementary information to characterize underlying mechanisms associated with brain functions. However, EEG data obtained from the simultaneous EEG-fMRI recordings are strongly influenced by MRI related artefacts, namely gradient artefacts (GA) and ballistocardiogram (BCG) artefacts. The GA is induced by temporally varying magnetic field gradients used for MR imaging, whereas the BCG artefacts are produced by cardiac pulse driven head motion in the strong magnetic field of the MRI scanner, so that this BCG artefact will be present when the subject is lying in the scanner, even when no fMRI data are acquired. When compared to corrections of the GA, the BCG artefact corrections are more challenging to remove due to its inherent variabilities and dynamic changes over time. Typically, the BCG artefacts obscure the EEG signals below 20Hz, and this remains problematic especially when the frequency of interest of EEG signals is below 20Hz, such as Alpha (8-13Hz) and Beta (13-30Hz) band EEG activity, or sleep spindle (11-16Hz) and slow-wave oscillations (<1 Hz) during sleep. The standard BCG artefact corrections, as for instance Average Artefact Subtraction method (AAS), require detecting cardiac pulse (R-peak) events from simultaneous electrocardiography (ECG) recordings. However, ECG signals in the MRI scanner are sometimes distorted and will become problematic for detecting reliable R-peaks. In this study, we focused on a beamforming technique, which is a spatial filtering technique to reject sources of signal variance that do not appear dipolar in the source space. This technique attenuates all unwanted source activities outside of a presumed region of interest without having to specify the location or the configuration of these underlying source signals. Specifically, in this study, we revisited the advantages of the beamforming technique to attenuate the BCG artefact in EEG-fMRI, and also to recover meaningful task-based induced neural signals during an attentional network task (ANT) which required participants to identify visual cues and respond as accurately and quickly as possible. We analysed EEG-fMRI data in 20 healthy participants when they were performing the ANT, and compared four different BCG correction approaches (non-BCG corrected, AAS BCG corrected, beamforming+AAS BCG corrected, beamforming BCG corrected). We demonstrated that beamforming BCG corrected data did not only significantly reduce the BCG artefacts, but also significantly recovered the expected task-based induced brain activity when compared to the standard AAS BCG corrections. Without detecting R-peak events from the ECG, this data-driven beamforming technique appears promising especially for longer data acquisition of sleep and resting EEG-fMRI. Our findings extend previous work regarding the recovery of meaningful EEG signals by an optimized suppression of MRI related artefacts. HighlightsO_LIBeamforming spatial filtering technique attenuates ballistocardiogram (BCG) artefacts in EEG-fMRI without detecting cardiac pulses in electrocardiography (ECG) recordings. C_LIO_LIBeamforming BCG denoising technique recovers expected task-based induced visual alpha and motor beta event-related desynchronization (ERD). C_LIO_LIBeamforming technique improves signal-noise ratios (SNR) of neural activities as compared to sensor level signals. C_LIO_LIData-driven beamforming technique appears promising for longer data acquisition of sleep and resting EEG-fMRI without relying on ECG signals. C_LI

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Uji, M., Cross, N., Pomares, F. B., Lina, J.-M., Dang-Vu, T. T., Grova, C.. 2020-11-27. Data-driven beamforming techniques to attenuate ballistocardiogram (BCG) artefacts in EEG-fMRI without detecting cardiac pulses in electrocardiography (ECG) recordings. https://doi.org/10.1101/2020.11.27.401851

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Epidermal Langerhans Cells Act as Neuroimmune Regulators of Pain and Itch

Neuroimmune interactions in the skin coordinate immune defense and somatosensory perception, yet how immune cells shape sensory signaling remains poorly defined. Here, we show that Langerhans cells (LCs), epidermal antigen-presenting cells, function as local immune-derived amplifiers of cutaneous sensory signaling. Anatomical and transcriptomic analyses reveal preferential LC association with non-peptidergic sensory neurons. LC activation increases neuronal and behavioral responses to thermal, mechanical, and pruritic stimuli without directly exciting sensory neurons, whereas LC inhibition or ablation selectively reduces pruritogen-evoked itch. We identified semaphorin 7A as a candidate LC-expressed mediator. Semaphorin 7A sensitized cultured sensory neurons to chloroquine and histamine, and neutralizing semaphorin 7A abolished the increase in chloroquine-evoked scratching produced by LC activation. Its receptor PlexinC1 was expressed by most MrgprA3 pruriceptors and blocking PlexinC1 reduced semaphorin 7A-evoked neuronal responses. Together, these findings identify epidermal LCs as local immune-derived amplifiers that regulate the responsiveness of cutaneous sensory circuits and identify semaphorin 7A as a mediator of LC-induced itch potentiation.

neuroscience↗

Feasible closed-loop stimulation for neural latent dynamics control

Modern neuroscience benefits from powerful computational and experimental methods for studying neural populations, including latent dynamics models that predict behavior with few dimensions. But despite their explanatory utility, latent factors are seldom targeted explicitly with experimental perturbations, leaving causal relationships to behavior and inferred dynamical landscapes untested. A promising solution is closed-loop, multi-channel optogenetic control, which, when paired with model predictions, could steer neural trajectories in real time--a feat impossible for traditional, hand-designed stimulation. However, because closed-loop latent control has not been demonstrated in vivo, the hardware and software requirements remain unclear--particularly the necessary stimulation dimensionality and how limited resources such as implant volume and bandwidth should be allocated between stimulation and recording capabilities. Preliminary experiments would thus help guide ongoing technological development. As large-scale exploration of these design spaces in vivo is prohibitively expensive, we conducted a high-throughput simulation survey using biophysically grounded spiking neural networks. We found that low-dimensional actuation is sufficient: in the reference configuration, ~20% of the stimulation channels achieved ~85% of peak control performance, far fewer than the number of neurons. Furthermore, allocating channels roughly equally between stimulation and recording optimized behavioral control, whereas pairing many electrodes with a single light source--the prevailing practice in experimental labs--performed poorly. Even without heavily optimizing modeling or control, we obtained >60% tracking error reduction and >90% evoked behavior accuracy on average for optimal channel counts. These results held across extensive parameter variations, suggesting that closed-loop latent control is feasible with accessible channel counts and establishing design principles for future tool development and in vivo experiments.

neuroscience↗

Identification of Kinome Biomarkers and Therapeutic Rescue in cGMP-Linked Retinal Degeneration

Inherited retinal degenerations, such as Retinitis Pigmentosa (RP) and Leber's congenital amaurosis (LCA), are major causes of progressive and irreversible vision loss. The large number of genes associated with these disorders makes their clinical and molecular characterization difficult, while systemic biomarkers for disease progression or treatment response remain limited. These challenges were addressed by targeting cGMP-associated mechanisms shared by RP and LCA and integrating systemic biomarker profiling with retinal outcomes. Kinase activity analysis (kinome analysis) in peripheral blood mononuclear cells distinguished healthy and diseased states and captured therapy-associated signatures in rd10 mice treated with LP-CN03, a liposomal formulation of the cGMP analog CN03. This first systemic analysis in a therapeutically responsive animal model highlights kinome analysis as a potential translational readout. Given shared cGMP signaling in RP and AIPL1-associated LCA, LP-CN03's therapeutic potential was further evaluated in a new CRISPR-Cas9-generated Aipl1-/- mouse model. Treatment with LP-CN03 preserved retinal structure and function, as shown by electroretinography, longitudinal optical coherence tomography, fundus imaging, optomotor testing, and photoreceptor-specific gene expression. Together, these findings provide independent in vivo evidence for the neuroprotective effect of LP-CN03 in both cGMP-related RP and LCA, also highlighting the translational value of kinome profiling.

neuroscience↗